Assignee
OREXO AB
SE32 patents
Top patents by PatentIndex Score
US10653690B1May 19, 2020
Pharmaceutical composition for nasal delivery
OREXO AB31 citations93
US8658198B2Feb 25, 2014
Non-abusable pharmaceutical composition comprising opioids
OREXO AB15 citations92
US7785626B2Aug 31, 2010
Gastric acid secretion inhibiting composition
OREXO AB18 citations88
US10729687B1Aug 4, 2020
Pharmaceutical composition for nasal delivery
OREXO AB11 citations84
US9439900B2Sep 13, 2016
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
OREXO AB5 citations84
US9259421B2Feb 16, 2016
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
OREXO AB5 citations84
US8980305B2Mar 17, 2015
Non-abusable pharmaceutical composition comprising opioids
OREXO AB9 citations84
US8940330B2Jan 27, 2015
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
OREXO AB5 citations84
US11957647B2Apr 16, 2024
Pharmaceutical composition comprising adrenaline
OREXO AB5 citations83
US10898480B1Jan 26, 2021
Pharmaceutical composition for nasal delivery
OREXO AB7 citations82
US8815911B2Aug 26, 2014
Alfentanil composition for the treatment of acute pain
OREXO AB11 citations79
US12268684B2Apr 8, 2025
Pharmaceutical composition for nasal delivery
OREXO AB3 citations73
US11737980B2Aug 29, 2023
Pharmaceutical composition for drug delivery
OREXO AB5 citations73
US10874661B2Dec 29, 2020
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
OREXO AB2 citations73
US12303472B2May 20, 2025
Pharmaceutical device for use in intranasal administration
OREXO AB3 citations72
US11617746B1Apr 4, 2023
Method of controlling depression in subjects treated for opioid dependence
OREXO AB2 citations71
US11433066B2Sep 6, 2022
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
OREXO AB0 citations63
US11020387B2Jun 1, 2021
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
OREXO AB0 citations63
US11020388B2Jun 1, 2021
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
OREXO AB0 citations63
US10946010B2Mar 16, 2021
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
OREXO AB0 citations63
US7910132B2Mar 22, 2011
Pharmaceutical composition for the treatment of acute disorders
OREXO AB3 citations62
US7815940B2Oct 19, 2010
Gastric acid secretion inhibiting composition
OREXO AB6 citations62
US12357573B2Jul 15, 2025
Pharmaceutical composition for drug delivery
OREXO AB0 citations61
US12138259B1Nov 12, 2024
Method of controlling depression in subjects treated for opioid dependence
OREXO AB0 citations61
US11986472B1May 21, 2024
Method of controlling alcohol consumption in subjects treated for opioid dependence
OREXO AB1 citations61
US11883392B2Jan 30, 2024
Pharmaceutical composition for nasal delivery
OREXO AB0 citations61
US12472154B2Nov 18, 2025
Pharmaceutical composition comprising adrenaline
OREXO AB0 citations60
US9345698B2May 24, 2016
Alfentanil composition for the treatment of acute pain
OREXO AB2 citations58
US9597281B2Mar 21, 2017
Pharmaceutical formulations useful in the treatment of insomnia
OREXO AB0 citations49
US6962687B1Nov 8, 2005
Method and means for detecting inflammatory processes
OREXO AB1 citations49
US9782396B2Oct 10, 2017
Alfentanil composition for the treatment of acute pain
OREXO AB0 citations47
US7771747B2Aug 10, 2010
Gastric acid secretion inhibiting composition
OREXO AB0 citations47